Abstract:In the brain, astrocytes secrete diverse substances that regulate neuronal function and viability. Exosomes, which are vesicles produced through the formation of multivesicular bodies and their subsequent fusion with the plasma membrane, are also released from astrocytes via exocytotic secretion. Astrocytic exosomes carry heat shock proteins that can reduce the cellular toxicity of misfolded proteins and prevent neurodegeneration. Although mutant huntingtin (mHtt) affects multiple functions of astrocytes, it remains unknown whether mHtt impairs the production of exosomes from astrocytes. We found that mHtt is not present in astrocytic exosomes, but can decrease exosome secretion from astrocytes in HD140Q knock-in (KI) mice. N-terminal mHtt accumulates in the nuclei and forms aggregates, causing decreased secretion of exosomes from cultured astrocytes. Consistently, there is a significant decrease in secreted exosomes in both female and male HD KI mouse striatum in which abundant nuclear mHtt aggregates are present. Conversely, injection of astrocytic exosomes into the striatum of HD140Q KI mice reduces the density of mHtt aggregates. Further, mHtt in astrocytes decreased the expression of αB-crystallin, a small heat shock protein that is enriched in astrocytes and mediates exosome secretion, by reducing the association of Sp1 with the enhancer of the αB-crystallin gene. Importantly, overexpression of αB-crystallin rescues defective exosome release from HD astrocytes as well as mHtt aggregates in the striatum of HD140Q KI mice. Our results demonstrate that mHtt reduces the expression of αB-crystallin in astrocytes to decrease exosome secretion in the HD brains, contributing to non-cell-autonomous neurotoxicity in HD.SIGNIFICANCE STATEMENT Huntington's disease (HD) is characterized by selective neurodegeneration that preferentially occurs in the striatal medium spiny neurons. Recent studies in different HD mouse models demonstrated that dysfunction of astrocytes, a major type of glial cell, leads to neuronal vulnerability. Emerging evidence shows that exosomes secreted from astrocytes contain neuroprotective cargoes that could support the survival of neighboring neurons. We found that mHtt in astrocytes impairs exosome secretion by decreasing αB-crystallin, a protein that is expressed mainly in glial cells and mediates exosome secretion. Overexpression of αB-crystallin could alleviate the deficient exosome release and neuropathology in HD mice. Our results revealed a new pathological pathway that affects the critical support of glial cells to neurons in the HD brain.

Effects of Exogenous Nub1 Expression in the Striatum of Hdq175/Q7 Mice

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression

NUB1 Suppression of Huntington Toxicity: Mechanistic Insights

N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy.

Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington disease models

Identification of Nub1 As A Suppressor of Mutant Huntingtin Toxicity Via Enhanced Protein Clearance

Region-specific pro-survival signaling and global neuronal protection by wild-type Huntingtin

Accumulation of Endogenous Mutant Huntingtin in Astrocytes Exacerbates Neuropathology of Huntington Disease in Mice

Expression of Mutant N-terminal Huntingtin Fragment (Htt552-100Q) in Astrocytes Suppresses the Secretion of BDNF

Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP.

Ubiquitin-Activating Enzyme Activity Contributes to Differential Accumulation of Mutant Huntingtin in Brain and Peripheral Tissues

Huntingtin Exon 1 Deletion Does Not Alter the Subcellular Distribution of Huntingtin and Gene Transcription in Mice.

Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.

Rhes Depletion Promotes Striatal Accumulation and Aggregation of Mutant Huntingtin in a Presymptomatic HD Mouse Model.

Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system

Loss of Hap1 Selectively Promotes Striatal Degeneration in Huntington Disease Mice

Inhibition of Neurite Outgrowth and Promotion of Cell Death by Cytoplasmic Soluble Mutant Huntingtin Stably Transfected in Mouse Neuroblastoma Cells

Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation.

Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease

Contribution of Nuclear and Extranuclear Polyq to Neurological Phenotypes in Mouse Models of Huntington's Disease.

Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice